GO
Gary Ostroff
Principal Investigator
GlucaDel
I'm working on
3 months ago
interestingVaccines, targeted drug delivery, antimicrobials, animal health
About
I work on glucan-based yeast particle platforms for subunit vaccines and macrophage-targeted delivery. We design encapsulation and controlled-release formulations that enhance stability, uptake, and efficacy of antimicrobials across human, animal, agricultural, and food applications.
GO
Gary Ostroff
Principal Investigator
GlucaDel
Work experience
GlucaDel
Principle
1999 - Present
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Not enough data yet.
Results may appear later and can be imperfect.
Last updated Jul 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.